AU2001258095A1 - Drug delivery systems for photodynamic therapy - Google Patents

Drug delivery systems for photodynamic therapy

Info

Publication number
AU2001258095A1
AU2001258095A1 AU2001258095A AU5809501A AU2001258095A1 AU 2001258095 A1 AU2001258095 A1 AU 2001258095A1 AU 2001258095 A AU2001258095 A AU 2001258095A AU 5809501 A AU5809501 A AU 5809501A AU 2001258095 A1 AU2001258095 A1 AU 2001258095A1
Authority
AU
Australia
Prior art keywords
drug delivery
delivery systems
photodynamic therapy
photodynamic
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001258095A
Inventor
Rubinah Kausar Chowdhary
David H. Dolphin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of British Columbia
Original Assignee
University of British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of British Columbia filed Critical University of British Columbia
Publication of AU2001258095A1 publication Critical patent/AU2001258095A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A61K9/1278—Post-loading, e.g. by ion or pH gradient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2001258095A 2000-05-08 2001-05-08 Drug delivery systems for photodynamic therapy Abandoned AU2001258095A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20264100P 2000-05-08 2000-05-08
US60/202,641 2000-05-08
PCT/CA2001/000637 WO2001085212A2 (en) 2000-05-08 2001-05-08 Drug delivery systems for photodynamic therapy

Publications (1)

Publication Number Publication Date
AU2001258095A1 true AU2001258095A1 (en) 2001-11-20

Family

ID=22750715

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001258095A Abandoned AU2001258095A1 (en) 2000-05-08 2001-05-08 Drug delivery systems for photodynamic therapy

Country Status (4)

Country Link
US (3) US6693093B2 (en)
AU (1) AU2001258095A1 (en)
CA (1) CA2408323C (en)
WO (1) WO2001085212A2 (en)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001085213A2 (en) * 2000-05-08 2001-11-15 The University Of British Columbia Supports for photosensitizer formulations
AU2001258095A1 (en) * 2000-05-08 2001-11-20 The University Of British Columbia Drug delivery systems for photodynamic therapy
AT408835B8 (en) * 2000-05-23 2002-07-25 Andreas Dipl Ing Dr Kubin PREPARATION OF HYPERICIN TIED TO POLYVINYLPYRROLIDONE (PVP) DIFFERENT GRADES OF POLYMERIZATION AND CROSSLINKING
US7431710B2 (en) 2002-04-08 2008-10-07 Glaukos Corporation Ocular implants with anchors and methods thereof
EP1465590B1 (en) * 2001-11-02 2008-03-26 The Governors Of The University Of Alberta Micelle compositions containing pegylated phospholipids and a photosensitizer
US7264629B2 (en) 2001-11-09 2007-09-04 Qlt, Inc. Photodynamic therapy for the treatment of hair loss
WO2003039596A1 (en) * 2001-11-09 2003-05-15 Qlt Inc. Photodynamic therapy for the treatment of hair loss
AU2003215352A1 (en) * 2002-02-20 2003-09-09 Spectra Systems Corporation Temperature control system for cutaneous photodynamic therapy
AU2005278020A1 (en) * 2004-07-22 2006-03-02 Ondine International Ltd. Sonophotodynamic therapy for dental applications
US20060052286A1 (en) * 2004-08-13 2006-03-09 Yale University Factor VII conjugates for selectively treating neovascularization disorders
WO2006096492A2 (en) * 2005-03-04 2006-09-14 Dusa Pharmaceuticals, Inc. Compositions and methods for reducing photosensitivity associated with photodynamic therapy
EP1933941A2 (en) 2005-08-25 2008-06-25 Philip R. Houle Treatment systems for delivery of sensitizer solutions
WO2007084981A2 (en) * 2006-01-19 2007-07-26 The Regents Of The University Of Michigan System and method for photoacoustic imaging and monitoring of laser therapy
WO2007100937A2 (en) * 2006-01-19 2007-09-07 The Regents Of The University Of Michigan System and method for spectroscopic photoacoustic tomography
EP2034963B1 (en) * 2006-05-18 2022-08-10 biolitec Unternehmensbeteiligungs II AG Gel-formulations of hydrophobic photosensitizers for mucosal applications
US8556950B2 (en) 2006-08-24 2013-10-15 Boston Scientific Scimed, Inc. Sterilizable indwelling catheters
US20080255549A1 (en) * 2006-10-18 2008-10-16 Ondine International, Ltd. Photodynamic therapy device
US20080123083A1 (en) * 2006-11-29 2008-05-29 The Regents Of The University Of Michigan System and Method for Photoacoustic Guided Diffuse Optical Imaging
US20080173093A1 (en) * 2007-01-18 2008-07-24 The Regents Of The University Of Michigan System and method for photoacoustic tomography of joints
WO2008103982A2 (en) * 2007-02-23 2008-08-28 The Regents Of The University Of Michigan System and method for monitoring photodynamic therapy
US7923021B2 (en) * 2007-07-24 2011-04-12 University Of Memphis Research Foundation Local delivery method and composition
US20090081605A1 (en) * 2007-09-25 2009-03-26 Ondine International, Ltd. Photodynamic therapy device adapted for use with scaler
US20090093470A1 (en) * 2007-10-08 2009-04-09 Ondine International, Ltd. Photodynamic therapy process and photosensitizer compositions therefor
CA2738928A1 (en) * 2008-10-03 2010-04-08 The Charlotte-Mecklenburg Hospital Authority D/B/A Carolinas Medical Cen Ter Treatment of hepatitis c infection with metalloporphyrins
US8252228B1 (en) * 2008-10-13 2012-08-28 Abbott Cardiovascular Systems Inc. Methods for sterilizing carriers for treatment of a kidney
US8703050B2 (en) * 2009-03-16 2014-04-22 Ondine International Ltd. Composition for photodynamic disinfection
US20100256125A1 (en) * 2009-04-06 2010-10-07 Zila Pharmaceuticals, Inc. Use of improved toluidine blue in photodynamic therapy
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
WO2011009020A2 (en) 2009-07-16 2011-01-20 Mallinckrodt Inc. Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers
US20130289520A1 (en) * 2010-04-23 2013-10-31 Children's Hospital Boston Targeted and light-activated cytosolic drug delivery
EP2598134B1 (en) 2010-07-30 2016-11-16 Advanced Photodynamic Technologies, Inc. Composition and method for photodynamic disinfection
US10245178B1 (en) 2011-06-07 2019-04-02 Glaukos Corporation Anterior chamber drug-eluting ocular implant
CN102793700B (en) * 2012-08-29 2014-03-12 郑州后羿制药有限公司 Compound oil emulsion injection containing flumequine and preparation method thereof
US10139385B2 (en) 2013-08-12 2018-11-27 Ecolab Usa Inc. Method of tracing chemical quantities using encapsulated fluorescent dyes
US10166321B2 (en) 2014-01-09 2019-01-01 Angiodynamics, Inc. High-flow port and infusion needle systems
EP3148491B1 (en) 2014-05-29 2020-07-01 Glaukos Corporation Implants with controlled drug delivery features and manufacturing method for said implants
AR100864A1 (en) * 2014-06-09 2016-11-09 Klox Tech Inc THERMOENDURECIBLE BIOPHOTONIC COMPOSITIONS AND THEIR USES
JP7017311B2 (en) * 2014-06-09 2022-02-08 広東科洛克生物医薬集団有限公司 Silicon-based bio-light composition and its use
US10975163B2 (en) 2015-01-15 2021-04-13 Oncoquest Pharmaceuticals Inc. Methods of increasing delivery of anti-cancer agents to targets
US11925578B2 (en) 2015-09-02 2024-03-12 Glaukos Corporation Drug delivery implants with bi-directional delivery capacity
WO2017053885A1 (en) 2015-09-25 2017-03-30 Glaukos Corporation Punctal implants with controlled drug delivery features and methods of using same
EP3442479A1 (en) 2016-04-20 2019-02-20 Harold Alexander Heitzmann Bioresorbable ocular drug delivery device
EP3471774A4 (en) 2016-06-16 2020-04-15 Oncoselect Therapeutics, LLC Porphyrin compounds and compositions useful for treating cancer
CN110520152A (en) 2017-03-14 2019-11-29 俄亥俄州创新基金会 Method and composition related with the IGG3 immunoconjugates of the target tissue factor
CN109966491B (en) * 2019-04-02 2022-03-08 南京师范大学 Antibacterial nano micelle capable of releasing photosensitizer and preparation method and application thereof
CN110151990B (en) * 2019-05-21 2021-09-28 福州大学 Phthalocyanine-temperature sensitive gel preparation and preparation method thereof

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4511641A (en) * 1983-02-02 1985-04-16 Minnesota Mining And Manufacturing Company Metal film imaging structure
US5171749A (en) 1987-01-20 1992-12-15 University Of British Columbia Wavelength-specific cytotoxic agents
US5173504A (en) 1989-04-21 1992-12-22 Health Research, Inc. Bacteriochlorophyll-a derivatives useful in photodynamic therapy
US5308608A (en) 1989-06-07 1994-05-03 University Of British Columbia Photosensitizing Diels-Alder porphyrin derivatives
US5726304A (en) 1992-10-30 1998-03-10 The University Of British Columbia Porphocyanine and CNC-expanded porphyrins
US5405957A (en) 1992-10-30 1995-04-11 The University Of British Columbia Wavelength-specific photosensitive compounds and expanded porphyrin-like compounds and methods of use
US5648485A (en) 1994-10-26 1997-07-15 University Of British Columbia β, β-dihydroxy meso-substituted chlorins, isobacteriochlorins, and bacteriochlorins
US5703230A (en) 1994-12-02 1997-12-30 University Of British Columbia Meso-monoiodo-substituted tetramacrocyclic compounds and methods for making and using the same
US5616342A (en) * 1995-04-11 1997-04-01 Pdt, Inc. Emulsioin suitable for administering a poorly water-soluble photosensitizing compound and use thereof
KR19990082383A (en) * 1996-02-16 1999-11-25 스티븐슨 린다 에스. Antimicrobial peptides and their use
US5883246A (en) 1996-03-07 1999-03-16 Qlt Phototherapeutics, Inc. Synthesis of polypyrrolic macrocycles from meso-substituted tripyrrane compounds
US5660119A (en) * 1996-06-28 1997-08-26 Plastic Systems, Inc. Lightweight structural beam
WO1998034644A1 (en) 1997-02-11 1998-08-13 Qlt Phototherapeutics, Inc. Compositions and articles for reducing the effects of inflammation
US6274614B1 (en) * 1997-02-11 2001-08-14 Qlt Inc. Methods, compositions and articles for reducing or preventing the effects of inflammation
US5880145A (en) 1997-05-07 1999-03-09 The University Of British Columbia Class of benzoporphyrin derivative photoactive compounds
EP0983273B8 (en) 1997-05-07 2002-10-09 QLT Inc. Ethylene glycol esters of monohydrobenzoporphyrin derivatives as photoactive agents
GB9721367D0 (en) 1997-10-09 1997-12-10 Univ Liverpool Delivery system
ES2331671T3 (en) 1998-04-03 2010-01-12 Mallinckrodt Inc. USEFUL NON-COVALENT BIOCONJUGATES FOR DIAGNOSIS AND THERAPY.
US7022843B1 (en) * 1999-04-14 2006-04-04 The University Of British Columbia β,β′-dihydroxy meso-substituted chlorins, isobacteriochlorins, and bacteriochlorins
AU4278400A (en) * 1999-04-14 2000-11-14 University Of British Columbia, The Improved beta,beta,-dihydroxy meso-substituted chlorins, isobacteriochlorins, and bacteriochlorins
WO2001085213A2 (en) * 2000-05-08 2001-11-15 The University Of British Columbia Supports for photosensitizer formulations
AU2001258095A1 (en) * 2000-05-08 2001-11-20 The University Of British Columbia Drug delivery systems for photodynamic therapy
EP1307226B1 (en) 2000-06-21 2008-11-19 Lantheus Medical Imaging, Inc. Vitronectin receptor antagonist pharmaceuticals

Also Published As

Publication number Publication date
WO2001085212A3 (en) 2002-08-08
US8968715B2 (en) 2015-03-03
US20070086973A1 (en) 2007-04-19
CA2408323C (en) 2012-06-12
US20020155089A1 (en) 2002-10-24
US6693093B2 (en) 2004-02-17
CA2408323A1 (en) 2001-11-15
WO2001085212A2 (en) 2001-11-15
US20040102430A1 (en) 2004-05-27

Similar Documents

Publication Publication Date Title
AU2001258095A1 (en) Drug delivery systems for photodynamic therapy
AU2001279064A1 (en) Therapeutic azo-compounds for drug delivery
EP1545662B8 (en) Drug delivery system
AU2123200A (en) Drug delivery device
AU2001235009A1 (en) Drug delivery apparatus
AU4985600A (en) Drug delivery device
HUP0401438A3 (en) Drug delivery system
AU2997500A (en) Single dose delivery device
IL155272A0 (en) Systems for optimized drug delivery
AU2001264887A1 (en) Drug delivery device
AU2002244142A1 (en) Integrated medication delivery system
AU4947100A (en) Drug delivery device
AU2002343555A1 (en) Eutectic-based self-nanoemulsified drug delivery system
HK1077523A1 (en) Proliposomal drug delivery system
AU2002353444A1 (en) Integrated transdermal drug delivery system
AU3520900A (en) Implantable drug delivery system
AUPR573001A0 (en) Lymphatic drug delivery system
AU2001270963A1 (en) Transdermal drug delivery system
AU2001243515A1 (en) Combination drug therapy
AU2002243290A1 (en) Transluminal drug delivery catheter
AU6503399A (en) Drug delivery catheter
AU2002218750A1 (en) Photoactivated drug therapy
AU2002222138A1 (en) Drug delivery system
AU2003285550A1 (en) Drug delivery system
AU2002210580A1 (en) Drug delivery system